PACAP (6-38) (human, chicken, mouse, ovine, porcine, rat) (trifluoro<wbr/>acetate salt)

PACAP (6-38) (human, chicken, mouse, ovine, porcine, rat) (trifluoroacetate salt)

CAT N°: 24554
Price:

From 348.00 295.80

Pituitary adenylate cyclase-activating peptide (PACAP) (6-38) is a PACAP receptor antagonist with IC50 values of 30, 600, and 40 nM, respectively for rat PAC1, rat VPAC1, and human VPAC2 recombinant receptors expressed in CHO cells.{41551} It binds to PACAP receptors in rat brain membrane (IC50 = 39.14 nM) and to SH-SY5Y and SK-N-MC human neuroblastoma and T47D human breast cancer cells (IC50s = 2.9, 129, and 227 nM, respectively).{41552,41553} In vivo, in newborn pigs, PACAP (6-38) (10 ?M) inhibits vasodilation of pial arterioles induced by PACAP (1-38) (Item No. 24770), the full-length peptide.{41554} It also inhibits decreased food intake and reduced body weight in rats induced by cocaine- and amphetamine-regulated transcript peptides (CARTp) following intracerebroventricular administration of 0.3-3 mol per animal doses.{41555}

We also advise you